Cipro Kit
NDC Package 50419-773-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Cipro (ciprofloxacin) kits is a medication used to treat a variety of bacterial infections. This formulation utilizes a kit delivery system. Marketed by Bayer Healthcare Pharmaceuticals Inc., this product is identified by NDC 50419-773 and is authorized under FDA application NDA020780.

Identification & Billing

NDC Package Code
50419-773-01
Package Description
1 KIT in 1 KIT * 100 mL in 1 BOTTLE, GLASS * 100 mL in 1 BOTTLE, GLASS
Product Code
50419-773
11-Digit Billing Format
50419077301
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Cipro
Non-Proprietary Name
Ciprofloxacin
Dosage Form
Kit - A packaged collection of related material.
Usage Information
This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Bayer Healthcare Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA020780
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-26-1997
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50419-773-01 identifies a specific commercial package of 1 kit in 1 kit * 100 ml in 1 bottle, glass * 100 ml in 1 bottle, glass of Cipro, a human prescription drug labeled by Bayer Healthcare Pharmaceuticals Inc.. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Healthcare Pharmaceuticals Inc. on September 26, 1997. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Bayer Healthcare Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50419077301. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50419-773-01
11-Digit CMS (5-4-2)
50419-0773-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.